Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

LXEO

Lexeo Therapeutics Inc

May 01 • 04:00PM ET

5.77

+0.07 1.32 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: CRSP QURE SRPT NTLA BEAM RARE BLUE EDIT SGMO ADVM

| Held by: VTI XBI IWM VXF IWN IBB VTWO KOMP DFAS DFMC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.19	Insider Own	20.18%	Shs Outstand	73.00M	Perf Week	-1.37%
Market Cap	427.48M	Forward P/E	-	EPS next Y	-1.36	Insider Trans	-0.48%	Shs Float	59.14M	Perf Month	1.76%
Enterprise Value	253.60M	PEG	-	EPS next Q	-0.31	Inst Own	104.27%	Short Float	21.31%	Perf Quarter	-22.13%
Income	-99.96M	P/S	-	EPS this Y	29.14%	Inst Trans	23.36%	Short Ratio	13.86	Perf Half Y	-41.78%
Sales	0.00M	P/B	1.71	EPS next Y	-3.49%	ROA	-47.48%	Short Interest	12.60M	Perf YTD	-41.89%
Book/sh	3.38	P/C	2.35	EPS next 5Y	25.90%	ROE	-55.00%	52W High	10.99 -47.50%	Perf Year	22.51%
Cash/sh	2.45	P/FCF	-	EPS past 3/5Y	5.73% -57.31%	ROIC	-39.69%	52W Low	2.43 137.45%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	5.05% 6.32%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	29.16%	Oper. Margin	-	ATR (14)	0.39	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	11.21	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	43.18	Recom	1.10
Dividend Gr. 3/5Y	- -	Current Ratio	11.21	EPS Q/Q	65.04%	SMA20	-6.83%	Beta	1.53	Target Price	20.60
Payout	-	Debt/Eq	0.03	Sales Q/Q	-	SMA50	-8.24%	Rel Volume	0.49	Prev Close	5.70
Employees	59	LT Debt/Eq	0.02	Earnings	Mar 30 AMC	SMA200	-18.31%	Avg Volume	909.30K	Price	5.77
IPO	Nov 03, 2023	Option/Short	Yes / Yes	EPS/Sales Surpr.	14.23% -	Trades		Volume	448,587	Change	1.32%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)